BHC 📈 Bausch Health Companies - Overview

Bausch Health Companies Inc. is a multinational corporation that operates in the specialty pharmaceutical and medical device sector, with a presence in the United States and international markets. The company's product portfolio encompasses a broad range of therapeutic areas, including gastroenterology, hepatology, neurology, dermatology, and eye health, among others. Its offerings include prescription and over-the-counter medications, as well as aesthetic medical devices. This diversified approach enables the company to cater to various patient needs and healthcare markets worldwide.

The company's organizational structure is divided into five distinct segments, each focusing on specific product categories and geographic regions. The Salix segment, for instance, concentrates on gastroenterology products in the United States, addressing conditions such as irritable bowel syndrome and inflammatory bowel disease. In contrast, the International segment has a more extensive product range, including aesthetic medical devices, branded and generic pharmaceuticals, and over-the-counter products, which are marketed globally. The Solta Medical segment specializes in the sale of aesthetic medical devices, such as those used for skin rejuvenation and body contouring. The Diversified segment offers a mix of pharmaceutical products in areas like neurology, ortho dermatology, and dentistry, primarily in the United States. Lastly, the Bausch + Lomb segment is dedicated to vision care, surgical, and ophthalmic pharmaceutical products, addressing various eye health needs.

Historically, the company was known as Valeant Pharmaceuticals International, Inc. before undergoing a rebranding effort in July 2018, resulting in its current name, Bausch Health Companies Inc. This transformation reflects the company's efforts to revamp its image and strategic direction. Headquartered in Laval, Canada, Bausch Health Companies Inc. is a publicly traded entity, with its common stock listed under the ISIN code CA0717341071, classified within the Pharmaceuticals sub-industry according to the Global Industry Classification Standard (GICS). The company's official website, https://www.bauschhealth.com, provides further information on its mission, products, and investor relations.